Direction des Relations Internationales (DRI)
1. Exchange of researchers
Erin Stretton is planned to make a short visit in Heidelberg (DKFZ) to better understand the tumor database.
From INRIA to the partner institution |
Number of people
|
Estimated cost
|
PhD student | 1: Erin Stretton | 2500 € (2 weeks) |
Total
|
1 | 2500 € |
Bjoern Menze will keep spending 25% of his time at the asclepios lab.
From the partner institution to INRIA |
Number of people
|
Estimated cost
|
Young researcher (Post-doc) |
1: Bjoern Menze | 7500 € (3 months) |
Total
|
1 | 7500 € |
2. Financial contribution from the international partner to the exchange program :
The salary of Bjoern Menze keeps beeing supported by the partner institution during his stay at INRIA.
Please indicate the amount of funding expected from the partner and from external resources :
8500 €
Associate Team budget proposal for year 1 (automated):
Global cost of the collaboration project: 18500 €
External resources (other than Associate Team program): 8500 €
Funding from the Associate Team program: 10000 €
ASSOCIATE TEAM |
CompuTumor |
selected in year
|
2010 |
Projet INRIA : ASCLEPIOS | Organisme étranger partenaire : MIT |
Unité de recherche INRIA
: INRIA SOPHIA ANTIPOLIS Thème INRIA : BIO |
Pays : ETATS UNIS |
Coordinateurs
français
|
Coordinateur
étranger
|
||||
Nom, prénom | Nicholas Ayache, PhD | Olivier Clatz, PhD | Polina Golland, PhD | Bjoern Menze, PhD | Bram Stieltjes, MD |
Grade/statut | Directeur de Recherche | Chargé de Recherche | Associate Professor | Research Associate | Associate Professor |
Organisme d'appartenance |
INRIA Sophia Antipolis, Projet Asclepios | Massachusetts Institute of Technology , Computer Science and Artificial Intelligence Laboratory (CSAIL) | DKFZ Heidelberg, diffusion group. | ||
Adresse postale | INRIA Sophia
Antipolis Asclepios Research Project 2004 route des Lucioles - BP 93 06902 Sophia Antipolis Cedex France |
MIT CSAIL 32 Vassar Street 32-D429 Cambridge, MA 02139 USA |
Department of Radiology, German Cancer Research Center, D-69120 Heidelberg, Germany. m.a.weber@dkfz.de | ||
URL | AYACHE | CLATZ | Golland | Menze | |
Téléphone | +33 4 92 38 76 61 | +33 4 92 38 71 59 | +1-617-253-5860 | +1-617-452-2124 | +49-6221-422492 |
Courriel | Nicholas.Ayache[at]sophia.inria.fr | olivier.clatz[at]sophia.inria.fr | fern[at]csail.mit.edu | menze[at]csail.mit.edu | B.Stieltjes[at]dkfz-heidelberg.de |
Title of the collaboration theme : Computational Brain Tumor |
Summary : The CompuTumor project is dedicated to the study of brain tumor models and their coupling with medical images to better assist diagnosis and therapy. The project will strongly enhance the current collaborations between INRIA and a group of world leading teams with complementary technical and clinical expertise on these topics in Boston and Nice. More specifically, the project aims at (a) proposing new medical image processing method that could be used to better analize tumor images, (b) developping new brain tumor models in order to personalise these models with patient data. |
1.
Objectifs scientifiques de la proposition
The CompuTumor project is dedicated to the study and development of brain tumor models for
improved therapy. This project aims at expanding the work of Asclepios in computational
brain tumor through the collaboration with world class leaders showing expertise in
complementary research domains. In the continuity of the research program proposed in the
previous
proposal, this new proposal will
extend our research along two main themes: (1) Medical image processing method for tumor
images (2) Brain
tumor growth modeling and personalisation of models. This scope of the project has been
reduced to cope with the more limited budget available in the renewal of a
team. It should be noted that an additional funding demand involving more
partners and having Thomas Deisboeck as a PI (Harvard) is currently under
review by NIH.
1. Medical image processing method for tumor images
Tumor images represent a chalenge for classical medical image processing algorithms. Indeed, state of the art segmentation and registration algorithms fail in the presence of lesion in the images. This weakness is due to the diversity in appearance of tumor in medical images. In particular, glial tumors tend to infiltrate the brain tissue which make the distinct identification of tumor tissue difficult. In this section, we will explore new areas of research to adapt existing tools to tumor images. In particular, the extension of the demons algorithms, as well as the developpment of new segmentation algorithms based on the random forest
2.
Brain Tumor Growth Modeling.
The
objective of this theme is to improve the existing models and to
develop new ones to include 1) the uncertainty on the growth of the
tumor, 2) the effect of various therapies and 3) a multi-scale modeling
approach from microscopic to macroscopic scales. In a first
stage, the research will be dedicated to the introduction of the notion
of uncertainty into the existing tools, and of its representation and
visualization in the medical images of a patient. The white matter
parameters, so far considered as spatially constant, will be evaluated
on specific fiber bundles. This will require identifying fiber clusters
within the white matter. We will develop methods to provide confidence
intervals into the estimated parameters. This confidence will highly
depend on the estimated noise on the data, modeling error as well as
error in the segmentation process. In a second stage we will
explore how to model various therapies and how to identify their
parameters from time series of medical images: existing microscopic
models for radiotherapy and chemotherapy will be reviewed and adapted
to the current models. Finally, a link between microscopic and
macroscopic models will be explored
2. Présentation des partenaires
3.
Impact
The three groups bring complementary strengths into the collaboration. While MIT medical vision groups brings image analysis methods, the asclepios groups provides expertise in the modeling of brain tumor and the personalisation of models. The DKFZ group comes with the necessary medical expertise and data needed to reach a high clinical impact.
We expect that the already developped algorithm between MIT and Asclepios for image processing, tumor modeling and paramenter estimation will be extended and evaluated on the large database already available at the DKFZ.